Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapy.

Alberto MinzoniLuca MazzettiPietro OrlandoGiuseppe LicciGiovanni TaccettiSilvia BresciGiandomenico Maggiore

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

ETI therapy demonstrates comprehensive improvements in CRS and olfactory function in CF patients, highlighting the potential of CFTR modulators in managing sinonasal manifestations.

Keyphrases

cystic fibrosis
chronic rhinosinusitis
pseudomonas aeruginosa
end stage renal disease
newly diagnosed
lung function
ejection fraction
prognostic factors
peritoneal dialysis
small molecule
risk assessment
climate change
human health
smoking cessation
replacement therapy